Home/Pipeline/Drug-Eluting Balloon Portfolio Expansion

Drug-Eluting Balloon Portfolio Expansion

Vascular Restenosis

Development/Commercial ExpansionActive

Key Facts

Indication
Vascular Restenosis
Phase
Development/Commercial Expansion
Status
Active
Company

About Translumina

Translumina is a privately held, commercial-stage medical device company specializing in interventional cardiology products. With a global manufacturing footprint and a portfolio centered on drug-eluting stents and balloons, the company has established a significant presence, particularly in India and other emerging markets. Its strategy combines in-house R&D with strategic acquisitions, such as Blue Medical Devices, to expand its technology portfolio and geographic reach. The company is positioned in the large and growing cardiovascular devices market, competing on quality, innovation, and cost-effectiveness.

View full company profile

Therapeutic Areas